Mesothelioma
Results
Phase 1/2
This study looked at seprehvir for people with mesothelioma of the lungs (pleural mesothelioma). Seprehvir is also called HSV1716.
It was open for people to join between 2012 and 2016. The team published the results in 2020.
Recruitment start: 15 October 2012
Recruitment end: 23 August 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Penella Woll
Experimental Cancer Medicine Centre (ECMC)
Sheffield Teaching Hospitals NHS Foundation Trust
VIRTTU Biologics
Last reviewed: 14 Sept 2021
CRUK internal database number: 9876